#5 · Tools & infrastructure
Computational models link genetic variants to RNA binding and cell-type expression
The dominant thread is computational inference of how genetic variation or molecular state maps to function and disease, using large multi-omics and single-cell resources. Within this, RNA-binding protein work is prominent: an expanded eCLIP resource covering 286 proteins in K562 and HepG2 supports deep-learning variant scoring and constraint estimates at binding sites, and MuSIC extends cross-species RBP-RNA prediction using RBP conservation across 11 species. CASE adds joint cell-type-specific and shared single-cell eQTL fine-mapping, reported to outperform SuSiE and mvSuSiE in simulation and OneK1K data. Multivariate genetic modeling resolves musculoskeletal disorders into three factors across 795 risk loci. Other items, including lncRNA prediction, driver-gene inference and survival mediation, apply related modeling to non-variant settings. Comparative claims are limited to the reported benchmarks.
Published papers
Modeling a continuum of drug-induced persistence during targeted cancer therapy.
Phenomenological model of plasticity-driven drug persisters in targeted cancer therapy; predicts an optimal drug concentration and drug holiday schedule.
Preprints
A multiscale pharmacokinetic-Boolean modelling framework for ibrutinib resistance in a Chronic Lymphocytic Leukaemia case study
Couples patient-specific ibrutinib pharmacokinetics with stochastic Boolean gene regulatory dynamics to model CLL relapse from single-cell data and screen BTK…
Leukemic fitness predicts treatment-free remission and guides adaptive therapy in chronic myeloid leukemia
Minimal two-equation CML model with immune compartment reduced via quasi-steady-state; leukemic fitness predicts treatment-free remission and guides adaptive…
Topic history
| Date | Rank |
|---|---|
| #5 | |
| #4 | |
| #4 | |
| #4 | |
| #2 | |
| #4 | |
| #3 | |
| #3 | |
| #2 | |
| #5 | |
| #4 | |
| #3 | |
| #3 | |
| #11 | |
| #15 | |
| #1 | |
| #6 | |
| #6 | |
| #4 | |
| #5 | |
| #16 |